Here are three points:
1. Mr. Sournac acquired 90,045 shares between Jan. 22 and Jan. 25.
2. Medicrea focuses on devolving products for personalized spine surgery, based on a data-driven and system-based approach.
3. The company develops spinal implant technologies that surgeons have used in 150,000-plus procedures.
More articles on devices:
Zimmer Biomet generates $7.8B in 2017 sales, spine segment sees 14% growth
Smith & Nephew opens specialized operations center in Costa Rica: 4 highlights
Dr. Michael Ries publishes book on inventing new hip, knee replacement devices — 5 highlights
